Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

has licenses to a diverse series of early patents and patent applications that were filed from 1998 to 2006 in the areas of RNAi target sequences, RNAi chemistry and RNAi delivery. The company was founded by CytRx and RNAi pioneers Craig Mello, Ph.D., 2006 Nobel Laureate for discovering RNAi and inventing RNAi therapeutics, Tariq M. Rana, Ph.D., inventor of fundamental technology for stabilizing RNAi and of RNAi nanotransporters, Greg Hannon, Ph.D., discoverer of RNAi mechanism (RISC) and short hairpin RNAi (shRNAi), and Michael Czech, Ph.D., a leader in the application of RNAi to diabetes and obesity. RXi's CEO, Tod Woolf, Ph.D., previously co-invented and commercialized STEALTH(TM) RNAi, one of the most widely used second-generation RNAi research products.

About the University of Massachusetts Medical School

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $176 million in research funding annually, 80 percent of which comes from federal funding sources. The work of UMMS researcher Craig Mello, PhD, an investigator of the prestigious Howard Hughes Medical Institute (HHMI), and his colleague Andrew Fire, PhD, then of the Carnegie Institution of Washington, toward the discovery of RNA interference was awarded the 2006 Nobel Prize in Physiology or Medicine, hailed as the "Breakthrough of the Year" in 2002 by Science magazine and has spawned a new and promising field of research, the global impact of which may prove astounding. UMMS is the academic partner of UMass Memorial Health Care, the largest health care provider in Central Massachusetts. For more information, visit www.umassmed.edu.

Forward-Looking Statements

This press release may contain forward-looking statements (statements as to matters other
'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:5/23/2013)... JERUSALEM , May 23, 2013  Hadasit Bio-Holdings ... portfolio of biotech companies, based on intellectual property ... Israel ,s foremost medical research center, ... Neurosciences Ltd., received significant funding from the Israeli ... Chief Scientist (OCS) to support product development and ...
(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... , , , , WALTHAM, Mass., Dec. ... and advisory firms for pharmaceutical and healthcare issues, finds that ... efficacy and side-effect profile, are cited most frequently by surveyed ... non-small-cell lung cancer treatment in Germany, France, Italy, Spain and ...
... HUNTINGTON BEACH, California and AMSTERDAM, December 17 ,Agendia, a ... US Food and Drug Administration (FDA) cleared its MammaPrint ... only FDA-cleared,breast cancer recurrence test available to patients and ... four clearances for MammaPrint, covering,all aspects of this important ...
Cached Medicine Technology:Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3FDA Broadens Clearance for Agendia's MammaPrint(R) 2
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 IBISWorld estimates ... grow at an average annual rate of 28.7% to $1.0 ... 17.9% in 2013. From 2002 and 2008, no new cell ... Culbert, causing relatively modest growth during that period. In the ... approved six new products. This factor contributed to the industry's ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Ayurveda ... medical science, its scope enters into the realms of the ... that disease is the end result of living out of ... one must discover where we are living out of harmony ... into perfect harmony. , The Foundations course in Mexico ( ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug ... all came together Saturday, May 18th to celebrate the company's ... the residents got up to thank Roy Duprez, CEO and ... to recovery, and giving them a second chance at life. ... after realizing the need for a long-term facility. What ...
(Date:5/25/2013)... The product liability lawyers at Wright ... on behalf of 23 property owners who live throughout the ... April 25, 2013 and names E.I. DuPont De Nemours and ... Schulte Imprelis lawsuits, this case will be litigated in the ... Imprelis lawsuit alleges that, due to the use ...
(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...
Breaking Medicine News(10 mins):Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 3Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 4Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3
... the time in emergency rooms , , TUESDAY, Dec. 18 (HealthDay ... someone is having a heart attack, they are mistaken 9.2 ... that minutes matter with these patients and doctors have to ... say researchers from the Minneapolis Heart Institute Foundation. , "Our ...
... three and older in the United States would carry ... the 2008 University of Louisville Grawemeyer Award in Education. ... nations young children, fill a gap for working families, ... boost the economy, award winners Edward Zigler, Walter Gilliam ...
... led by Mayo Clinic have designed a technique that uses ... cells that spread from primary tumors to other parts of ... shows that this technology could be the basis for a ... appeared in the Dec. 9 online issue of Nature Medicine. ...
... inexpensive infection control measures, hospitals around the world could prevent ... TB), according to a new study in The Lancet by ... Wings for its ability to spread and kill rapidly, XDR ... identified in all regions of the world, including the United ...
... for patients with spinal cord injuries can stimulate ... compensatory changes in the brain, say Canadian researchers. ... function and the ability to walk. , A ... the remarkable benefits of rehabilitation training after a ...
... remains America,s No. 1 killer, AHA says , , TUESDAY, ... death rates in the United States are declining, the ... the nation, according to the American Heart Association. , ... for many people, according to the American Heart Association,s ...
Cached Medicine News:Health News:Diagnosis of Heart Attack Can Be Wrong 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Simple strategy could prevent half of deadly tuberculosis infections 2Health News:Intensive training post-spinal cord injury can stimulate repair in brain and spinal cord 2Health News:U.S. Heart Disease Death Rates Falling 2Health News:U.S. Heart Disease Death Rates Falling 3
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region....
... also known as BMP-7, is a member of ... Bone Morphogenetic Proteins. OP-1 Implant is known to ... mature skeletal systems. The FDA approved OP-1 Implant ... 2001. OP-1 Implant is now available across the ...
... Connect allografts are dense ... anterior cortical face providing structural ... for rapid healing. These allografts ... Non-Lordotic designs. Connect allografts are ...
... maxillo-facial and cranial surgery are characterized by ... for the most varied of applications. Tailor-made ... that the system is easy to implement ... from titanium. Specially designed instruments for drilling, ...
Medicine Products: